Commentary · 31 Jan 2025
Short communicationPublished 15 Jul 2020
Drug Discovery Meet 2020-Olanzapine mesoporous nanostructured lipid carrier: Characterization and Physiologically based Pharmacokinetic Modeling
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
A promising approach has been emerging to enhance dissolution of hydrophobicdrugsby encapsulation in mesoporous silica materials. Olanzapine is a practically insolubleantipsychotic drug which is subjected to excessive first pass effect and shows inadequate oral bioavailability. Therefore, mesoporous silica was used to improve bioavailability of olanzapine incorporated in nano-structured lipid carriers (NLCs). These systems were characterized for their particle size, polydispersity index (PDI), Zeta potential, entrapment efficiency (EE) and differential scanning calorimetry (DSC) as well asits release profile.The optimized NLC system (F4) displayed nano-spherical particles (120.5 nm), possessed high entrapment efficiency (88.46 %) and the highest percentage of drug released after six hours (75.13%). The biological performance of the optimized system was assessed in comparison with the drug suspension in healthy albino rabbits. The optimized system showed significantly (P < 0.05) prolonged MRT (8.47 h), higher Cmax (22.12±0.4ng/ml) and Tmax (2.0 h) values compared to drug suspension.Physiologically based pharmacokinetic (PBPK) model was simulated and verified, then the predicted pharmacokinetic results were compared to the results of the in vivo study. All the predicted results were within 0.5-2-fold of the observed and the reported data. To seta conclusion,in vitroresults as well as in vivopharmacokinetic studyand PBPK data showed an enhancement in bioavailability ofthe optimized NLCs systemover the plain drug suspension. These results provedthe potential of incorporated NLC mesoporous silica for a significant improvement in oral bioavailability of olanzapine.
Subjects
ChemistryPharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Chemical Biology & Pharmaceutical Chemistry.
Brief report · 31 Jan 2025
Chemical Biology Approaches to Modulate Protein–protein Interactions in Cancer Therapy
Opinion · 31 Jan 2025
Advances in Nanocarrier-based Drug Delivery: Bridging Chemistry and Pharmacology
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Chemical Biology & Pharmaceutical Chemistry
- SubjectChemistry
- SubjectPharmaceutical Sciences
